- 专利标题： Type I diabetes therapy
-
申请号： US16637304申请日： 2018-08-07
-
公开(公告)号： US11806386B2公开(公告)日： 2023-11-07
- 发明人: Helen E. Thomas , Thomas W. H. Kay , Balasubramanian Krishnamurthy , Gaurang Jhala
- 申请人： St. Vincent's Institute of Medical Research
- 申请人地址： AU Fitzroy
- 专利权人： St. Vincent's Institute of Medical Research
- 当前专利权人： St. Vincent's Institute of Medical Research
- 当前专利权人地址： AU Fitzroy
- 代理机构： Wolf, Greenfield & Sacks, P.C.
- 优先权： AU 17903125 2017.08.07
- 国际申请： PCT/AU2018/050823 2018.08.07
- 国际公布： WO2019/028503A 2019.02.14
- 进入国家日期： 2020-02-07
- 主分类号： A61K38/28
- IPC分类号： A61K38/28 ; A61P3/10 ; A61K31/437 ; A61K31/4985 ; A61K31/519 ; A61K31/529 ; A61K31/5355 ; A61K31/541 ; A61K31/553 ; A61K38/17 ; A61K38/46 ; A61K38/51
摘要：
The present invention relates to novel methods and therapies for treating, preventing or delaying the onset of type 1 diabetes. In one aspect, the invention provides a method of preventing, delaying the onset of, or delaying the progression of, type 1 diabetes (T1D) in an individual, the method comprising providing in the individual an anti-inflammatory compound; and a pancreatic autoantigen or a derivative or variant thereof; thereby preventing, delaying the onset of, or delaying the progression of, T1D in the individual.
公开/授权文献
- US20200345815A1 TYPE I DIABETES THERAPY 公开/授权日：2020-11-05
信息查询
IPC分类:
